June 16, 2025 09:16 PM EDT
R&D
Pharma

Fired vac­cine ad­vi­sors de­fend ACIP’s work, in­de­pen­dence in joint ed­i­to­r­i­al

Max Bayer

Pharma Reporter

All 17 oust­ed mem­bers of a key CDC vac­cine pan­el say their abrupt dis­missals “have left the US vac­cine pro­gram crit­i­cal­ly weak­ened,” ac­cord­ing to a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

What's com­ing in five years? FDA chief points to uni­ver­sal flu vac­cine, new ap­proval path­way

Up­dat­ed: Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

Ab­b­Vie’s can­cer drug fails Phase 3 com­bo study to treat oth­er bone mar­row dis­eases

Roche moves ahead with Phase 3 Parkin­son’s study de­spite mixed tri­al re­sults

NextCure inks ADC deal with Shang­hai drug­mak­er

sponsored

This com­pa­ny has spent a decade in­no­vat­ing NGS-based com­pan­ion di­ag­nos­tics world­wide–what’s next?

A service from the Financial Times